Not yet recruiting
Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors
NCT07789327
- Conditions
- Efficacy, Safety, Tolerability
- Locations
-
Not specified